Exploring 2016 Wmif Disruptive Dozen 9
Let's dive into the details surrounding 2016 Wmif Disruptive Dozen 9.
- Cellular Immunotherapy Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter D.
- CRISPR: Genome Editing and Cancer Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J.
- The Microbiome and Cancer Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ...
- Epigenetics and Cancer Treatment Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J.
- Moderators: Calum MacRae, MD, PhD, Chief of Cardiovascular Medicine, Brigham and Women's Hospital; Associate Professor of ...
In-Depth Information on 2016 Wmif Disruptive Dozen 9
mHealth and Cancer Care Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ... Patient-Specific Research to Enable Efficient Drug Development Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer ... Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of Surgery, Harvard Medical School ... Machine Learning and Computational Biology to Transform Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH ...
9
That wraps up our extensive overview of 2016 Wmif Disruptive Dozen 9.
